Simple. He missed refilling on the spike down to $2.35 this morning. He was too greedy. However, he knows the EU market is seven times the size of Canada and he needs to re-establish a position before the beginning of the second week of June, i.e., before the EMA decision on approving Vitaros.
Remember folks: "This week, which marked day 180 of the regulatory approval process, the RMS (The Netherlands) confirmed that the major nonclinical, clinical and clinical safety issues outlined in the Day 120 List of Questions had been resolved." (from today's conference call)